文献速递头颈外科

生物信息学方法结合实验验证揭示OAS3基因参与头颈癌紫杉醇耐药

Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer.
PubMed 文献 · Head Neck · 2024-05-16

本研究通过芯片数据生物信息学分析筛选与紫杉醇耐药相关的候选基因,并在紫杉醇耐药的头颈鳞状细胞癌细胞系及临床标本中验证其功能。分析显示OAS3在紫杉醇耐药癌细胞中上调并与耐药相关;下调OAS3可诱导凋亡及G0/G1期细胞周期阻滞,显著降低耐药SCC-9细胞的活力和集落形成能力。作者认为靶向OAS3可能使高表达OAS3的紫杉醇耐药HNSCC细胞对紫杉醇治疗重新敏感。

要点

  • 生物信息学分析显示OAS3在紫杉醇耐药癌细胞中上调并与耐药相关。
  • 下调OAS3可诱导凋亡和G0/G1期阻滞,降低耐药SCC-9细胞活力和集落形成。
  • 作者认为靶向OAS3可能使高表达OAS3的耐药HNSCC细胞对紫杉醇重新敏感。

核心结论

  • 作者认为靶向OAS3可能使高表达OAS3的紫杉醇耐药HNSCC细胞对紫杉醇治疗重新敏感。

研究设计与样本

  • 分析含不同类型癌症紫杉醇耐药样本的芯片数据序列,并用多种生物信息学工具鉴定与紫杉醇耐药相关的候选基因。
  • 在紫杉醇耐药的FaDu和SCC-9细胞系中抑制目标基因表达后,评估细胞活力和集落形成能力的变化。

主要发现

  • 对紫杉醇耐药癌细胞中上调基因的生物信息学分析表明,OAS3与紫杉醇耐药相关。
  • 下调OAS3表达通过诱导凋亡和G0/G1期细胞周期阻滞,显著降低紫杉醇耐药SCC-9细胞的活力和集落形成能力。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to identify a candidate gene associated with paclitaxel (PTX) resistance and to evaluate functionally its biological role in the PTX-resistant head and neck squamous cell carcinoma (HNSCC) cell lines and clinical specimens. METHODS: Microarray data series containing samples of different types of cancers resistant to PTX were analyzed and then a candidate gene associated with PTX resistance was identified using various bioinformatics tools. After the suppression of the target gene expression, changes in cell viability and colony-forming ability were evaluated in PTX-resistant FaDu and SCC-9 cell lines. RESULTS: Bioinformatics analyses of upregulated genes in PTX-resistant cancer cells indicated that OAS3 was associated with PTX resistance. The downregulation of OAS3 expression significantly reduced the viability and colony-forming capacity of PTX-resistant SCC-9 cells by inducing apoptosis and cell cycle arrest at G0/G1 phase. CONCLUSIONS: The therapeutic targeting of OAS3 may resensitize PTX-resistant HNSCC cells with high OAS3 expression to PTX treatment.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Caglar HO, Aytatli A, Barlak N, et al. Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer. Head Neck. 2024. PMID: 38752376. doi:10.1002/hed.27803

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。